Skip to main content
. Author manuscript; available in PMC: 2008 Feb 4.
Published in final edited form as: J Immunother. 2004;27(6):472–477. doi: 10.1097/00002371-200411000-00007

TABLE 4.

Immunologic Responses to the HLA-A2-Restricted NY-ESO-1 Peptides

# of Vaccinations
0
2
4
8
16
Group ESO(N) ESO(9V) ESO(N) ESO(9V) ESO(N) ESO(9V) ESO(N) ESO(9V) ESO(N) ESO(9V)
1 0/3 0/5 0/1 nd 1/2 3/5 nd 1/1 nd 1/1
2 0/3 0/7 1/3 2/5 1/1 4/5 nd 1/1
3 0/5 1/7 4/5 7/7 0/1 2/2 1/1 1/1
4 1/10 1/10 2/10 3/10 2/5 3/5 1/1 1/1
Total 1/21 2/29 7/19 12/22 4/9 12/17 2/2 4/4 nd 1/1

nd, not done.